Polymorphs of dasatinib, preparation methods and pharmaceutical compositions thereof

摘要

Polymorph I of dasatinib monohydrate and polymorph II of dasatinib, their preparation methods and pharmaceutical compositions containing the same are provided. These polymorphs have better physicochemical properties, are more stable, and are more suitable for industrial scale production.